PRKACA and prostate carcinoma: A preclinical study demonstrated that crotonylation of PRKACA enhances the activity of PKA and thereby promotes colorectal cancer development via the PKA-FAK-AKT pathway, whereas PRKACA is secreted by prostate cancer cells [11].